<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-96153</identifier>
<setSpec>0004-0614</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Bladder augmentation using the gastrointestinal tract. Indication, follow up and complications</dc:title>
<dc:description xml:lang="en">RESULTS: We included 24 patients, 19 women and 5 men with a mean age of 48.5 years and a median of 47 (21-77). Mean follow up was 7.5 years with a median of 8 (1-11). The indications were: 7 interstitial cystitis, 8 bladder retraction and 7 neurogenic bladder. There were no intraoperative complications. The postoperative complications were 3 Clavien I, 2 type II, 2 IIIA and 1 IIIB.In the long term, 3 patients presented urinary incontinence, 2 mild metabolic acidosis, 5 required self-catheterization, 6 bladder stones, 2 febrile urinary tract infections and 1 stricture of the anastomotic mouth. In three cases, an ileogastrocystoplasty was performed without hydroelectrolytic impairment or impairment of kidney function.CONCLUSIONS: In selected patients, augmentation enterocystoplasty constitutes an efficacious therapeutic option in the treatment of lower urinary tract dysfunction with scant morbidity and few complications(AU)</dc:description>
<dc:creator>Ogaya Piniés, G</dc:creator>
<dc:creator>Escribano Patiño, G</dc:creator>
<dc:creator>Hernández Fernández, C</dc:creator>
<dc:creator>Molina Escudero, R</dc:creator>
<dc:creator>Husillos Alonso, A</dc:creator>
<dc:creator>Rodríguez Fernández, E</dc:creator>
<dc:creator>Lledó García, E</dc:creator>
<dc:creator>Cancho Gil, M. J</dc:creator>
<dc:creator>Piñero Sánchez, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">RESULTADOS: Incluimos 24 pacientes, 19 mujeres y 5 varones con una edad media de 48,5 años y una mediana de 47 (21-77). El seguimiento medio fue de 7,5 años con una mediana de 8. Las indicaciones fueron: 7 cistitis intersticiales, 9 retracciones vesicales y 8 vejigas neurógenas. No hubo complicaciones intraoperatorias. Las complicaciones postoperatorias fueron 3 Clavien I, 2 tipo II, 2 IIIa y 1 IIIb. A largo plazo 3 pacientes presentan incontinencia urinaria, 2 acidosis metabólica leve, 5 precisan autocateterismos, 6 litiasis vesicales, 2 infecciones urinarias febriles y 1 estenosis de la boca anastomótica. En tres casos se realizó ileogastrocistoplastia sin deterioro hidroelectrolitico ni de la función renal.CONCLUSIONES En pacientes seleccionados la enterocistoplastia de aumento constituye una opción terapéutica eficaz con escasa morbilidad y complicaciones en el tratamiento de la disfunción del tracto urinario inferior(AU)</dc:description>
<dc:source>Arch Esp Urol;64(10): 953-959, dic. 2011. tab</dc:source>
<dc:identifier>ibc-96153</dc:identifier>
<dc:title xml:lang="es">Ampliación vesical con uso de aparato digestivo. Indicaciones, seguimiento y complicaciones</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d29754^s22074</dc:subject>
<dc:subject>^d1775^s22009</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d30912^s22074</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d53386</dc:subject>
<dc:subject>^d14947^s22045</dc:subject>
<dc:subject>^d32783^s22009</dc:subject>
<dc:type>article</dc:type>
<dc:date>201112</dc:date>
</metadata>
</record>
</ibecs-document>
